Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 21, 2024

SELL
$13.84 - $20.79 $117,847 - $177,026
-8,515 Reduced 34.76%
15,985 $233,000
Q3 2023

Nov 07, 2023

SELL
$13.84 - $20.79 $117,847 - $177,026
-8,515 Reduced 34.76%
15,985 $233,000
Q2 2023

Oct 21, 2024

BUY
$10.7 - $17.48 $24,610 - $40,204
2,300 Added 10.36%
24,500 $416,000
Q2 2023

Aug 07, 2023

BUY
$10.7 - $17.48 $24,610 - $40,204
2,300 Added 10.36%
24,500 $416,000
Q1 2023

Oct 21, 2024

BUY
$6.45 - $14.48 $143,190 - $321,456
22,200 New
22,200 $310,000
Q1 2023

May 03, 2023

BUY
$6.45 - $14.48 $143,190 - $321,456
22,200 New
22,200 $310,000
Q2 2022

Aug 09, 2022

BUY
$4.6 - $8.82 $96,599 - $185,220
21,000 New
21,000 $100,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $217M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.